Rückert R - Search Results

1

Interleukin-15 protects from lethal apoptosis in vivo.

Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Rückert R, Krause H, Kunzendorf U. Bulfone-Paus S, et al. Among authors: ruckert r. Nat Med. 1997 Oct;3(10):1124-8. doi: 10.1038/nm1097-1124. Nat Med. 1997. PMID: 9334724

2

Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.

Bulfone-Paus S, von Bernuth H, Rückert R, Wachtlin J, Ungureanu D, Notter M, Krause H, Pohl T, Paus R, Kunzendorf U. Bulfone-Paus S, et al. Among authors: ruckert r. Cancer Res. 1998 Jul 1;58(13):2707-10. Cancer Res. 1998. PMID: 9661877

3

IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL-2-IgG2b fusion protein inhibits both.

Rückert R, Herz U, Paus R, Ungureanu D, Pohl T, Renz H, Bulfone-Paus S. Rückert R, et al. Eur J Immunol. 1998 Oct;28(10):3312-20. doi: 10.1002/(SICI)1521-4141(199810)28:10<3312::AID-IMMU3312>3.0.CO;2-I. Eur J Immunol. 1998. PMID: 9808200 Free article.

4

Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain.

Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R, Krause H. Bulfone-Paus S, et al. Among authors: ruckert r. FASEB J. 1999 Sep;13(12):1575-85. doi: 10.1096/fasebj.13.12.1575. FASEB J. 1999. PMID: 10463949 Retracted.

5

An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.

Bulfone-Paus S, Rückert R, Krause H, von Bernuth H, Notter M, Pohl T, Tran TH, Paus R, Kunzendorf U. Bulfone-Paus S, et al. Among authors: ruckert r. Transplantation. 2000 Apr 15;69(7):1386-91. doi: 10.1097/00007890-200004150-00030. Transplantation. 2000. PMID: 10798759 Retracted.

6

High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo.

Rückert R, Lindner G, Bulfone-Paus S, Paus R. Rückert R, et al. Br J Dermatol. 2000 Nov;143(5):1036-9. doi: 10.1046/j.1365-2133.2000.03784.x. Br J Dermatol. 2000. PMID: 11069516

7

IL-2-IgG2b fusion protein suppresses murine contact hypersensitivity in vivo.

Rückert R, Brandt K, Hofmann U, Bulfone-Paus S, Paus R. Rückert R, et al. J Invest Dermatol. 2002 Aug;119(2):370-6. doi: 10.1046/j.1523-1747.2002.01849.x. J Invest Dermatol. 2002. PMID: 12190859 Free article.

8

Interleukin-21 inhibits dendritic cell activation and maturation.

Brandt K, Bulfone-Paus S, Foster DC, Rückert R. Brandt K, et al. Among authors: ruckert r. Blood. 2003 Dec 1;102(12):4090-8. doi: 10.1182/blood-2003-03-0669. Epub 2003 Jul 31. Blood. 2003. PMID: 12893770 Free article.

9

Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo.

Brandt K, Bulfone-Paus S, Jenckel A, Foster DC, Paus R, Rückert R. Brandt K, et al. Among authors: ruckert r. J Invest Dermatol. 2003 Dec;121(6):1379-82. doi: 10.1046/j.1523-1747.2003.12603.x. J Invest Dermatol. 2003. PMID: 14675186 Free article.

10

Inhibition of chemotherapy-induced keratinocyte apoptosis in vivo by an interleukin-15-IgG fusion protein.

Lindner G, Rückert R, Bulfone-Paus S, Paus R. Lindner G, et al. Among authors: ruckert r. J Invest Dermatol. 1998 Apr;110(4):457-8. doi: 10.1046/j.1523-1747.1998.00141.x. J Invest Dermatol. 1998. PMID: 9540993 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page